Nakatsu, Japan

Kazuhiro Goto

This inventor holds 7 USPTO granted patents. Top assignee: Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1977-1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuhiro Goto. Retrieved from https://idiyas.com/inventor/kazuhiro-goto-txb2g51k

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Nakatsu, JA (1977)
  • Nakatsu, JP (1979 - 1985)

Company Filing History:


Years Active: 1977-1985

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Kazuhiro Goto: Innovator in Pharmaceutical Development

Introduction

Kazuhiro Goto is a prominent inventor based in Nakatsu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents. With a total of 7 patents to his name, Goto has established himself as a key figure in medical innovation.

Latest Patents

Among his latest patents, Goto has developed a therapeutic agent for hypertension, which includes Bis-(aminoalkoxy)-phenyl and pyridyl ketones. This innovative work showcases his commitment to addressing critical health issues through scientific research and development.

Career Highlights

Kazuhiro Goto is currently employed at Yoshitomi Pharmaceutical Industries, Ltd., where he continues to push the boundaries of pharmaceutical science. His work has not only advanced the company's research initiatives but has also contributed to the broader medical community.

Collaborations

Throughout his career, Goto has collaborated with notable colleagues, including Takanori Oe and Masao Hisadome. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Kazuhiro Goto's contributions to pharmaceutical innovation are noteworthy, and his ongoing work promises to impact the field significantly. His dedication to developing effective therapeutic agents exemplifies the spirit of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…